99 episodes

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

Neurology Today in 5 American Academy of Neurology

    • Health & Fitness
    • 4.7 • 17 Ratings

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

    Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab

    Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab

    In this week’s podcast, Neurology Today’s editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.

    • 5 min
    Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology

    Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology

    In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI’s use in sleep neurology.

    • 5 min
    When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.

    When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.

    In this week’s podcast, Neurology Today’s editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications.
    This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.  

    • 4 min
    Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics

    Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics

    In this week’s podcast, Neurology Today’s editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracerebral hemorrhage, new findings showing people with Havana syndrome have functional neurologic disorder, and a study reporting distal symmetric polyneuropathy is more prevalent but less diagnosed in primary care clinics in low-income areas.  
    This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

    • 5 min
    Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers

    Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers

    In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intracerebral hemorrhage, disparities in access to diagnosis and care for epilepsy, and the challenges that remain for women in neurology research.

    • 4 min
    Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies

    Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies

    Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors’ response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.

    • 4 min

Customer Reviews

4.7 out of 5
17 Ratings

17 Ratings

foxxy714 ,

Thank you!

Very Helpful material.

Top Podcasts In Health & Fitness

The School of Greatness
Lewis Howes
Huberman Lab
Scicomm Media
On Purpose with Jay Shetty
iHeartPodcasts
ZOE Science & Nutrition
ZOE
Passion Struck with John R. Miles
John R. Miles
Ten Percent Happier with Dan Harris
Ten Percent Happier

You Might Also Like

Neurology® Podcast
American Academy of Neurology
Neurology Exam Prep Podcast
Neurology Exam Prep Podcast
Neurology Minute
American Academy of Neurology
Practical Neurology Podcast
BMJ Group
Continuum Audio
American Academy of Neurology
JAMA Neurology Author Interviews
JAMA Network